Rigel Pharmaceuticals | DŁUG





DŁUG Zmiana Data
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.59B 1.62B 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
AstraZeneca USD 32.63B 207M 2025-09
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Celldex Therapeutics USD 2.62M 410K 2025-09
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Halozyme Therapeutics USD 1.51B 1.65M 2025-06
Heron Therapeutics USD 149.65M 157K 2024-09
Intrexon USD 0 13.82M 2024-06
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
Ligand Pharmaceuticals USD 5.74M 5.72M 2025-06
MacroGenics USD 37.01M 238K 2025-09
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Pfizer USD 60.85B 78M 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Veracyte USD 50.65M 145K 2025-06


Rigel Pharmaceuticals DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.